Total Payments
$860.50
2023 Payments
$99.00
Companies
17
Transactions
48
Medicare Patients
11,918
Medicare Billing
$6.9M
Payment Breakdown by Category
Food & Beverage$699.63 (81.3%)
Education$160.87 (18.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $699.63 | 45 | 81.3% |
| Education | $160.87 | 3 | 18.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $376.81 | 16 | $0 (2023) |
| PFIZER INC. | $106.42 | 7 | $0 (2022) |
| Genentech USA, Inc. | $100.23 | 5 | $0 (2021) |
| AbbVie, Inc. | $49.51 | 4 | $0 (2018) |
| Amgen Inc. | $43.01 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $37.32 | 3 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $17.01 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $15.17 | 1 | $0 (2018) |
| ARRAY BIOPHARMA INC | $15.10 | 1 | $0 (2020) |
| Karyopharm Therapeutics Inc. | $14.88 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
| 2022 | $102.02 | 5 | Janssen Biotech, Inc. ($54.93) |
| 2021 | $94.44 | 4 | Genentech USA, Inc. ($49.95) |
| 2020 | $46.01 | 3 | Janssen Biotech, Inc. ($18.21) |
| 2019 | $70.71 | 4 | Janssen Biotech, Inc. ($57.61) |
| 2018 | $293.92 | 21 | Janssen Biotech, Inc. ($91.75) |
| 2017 | $154.40 | 10 | Genentech USA, Inc. ($37.78) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/07/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 05/27/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 03/24/2022 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 03/21/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2022 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Oncology | ||||||
| 02/21/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Oncology | ||||||
| 07/21/2021 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Oncology | ||||||
| 07/12/2021 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/26/2021 | Genentech USA, Inc. | Erivedge (Biological) | Education | In-kind items and services | $49.95 | General |
| Category: BioOncology | ||||||
| 12/20/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 11/11/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Oncology | ||||||
| 10/28/2020 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
| 06/20/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 05/20/2019 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Hematology | ||||||
| 02/28/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 11/13/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Oncology | ||||||
| 09/12/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Oncology | ||||||
| 07/18/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2018 | PFIZER INC. | MYLOTARG (Biological), BOSULIF, BESPONSA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2018 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Virology | ||||||
| 06/13/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 05/22/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 54 | 2,595 | 96,734 | $3.5M | $1.2M |
| 2022 | 53 | 2,752 | 118,066 | $5.2M | $2.0M |
| 2021 | 55 | 3,458 | 157,404 | $6.6M | $2.5M |
| 2020 | 54 | 3,113 | 85,780 | $3.1M | $1.2M |
Total Patients
11,918
Total Services
457,984
Medicare Billing
$6.9M
Procedure Codes
216
All Medicare Procedures & Services
216 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 27 | 13,200 | $1.4M | $561,673 | 40.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 55 | 5,700 | $258,360 | $102,588 | 39.7% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 12 | 2,610 | $234,030 | $93,454 | 39.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 2,050 | $208,525 | $64,099 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 604 | $154,143 | $53,798 | 34.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 164 | 435 | $111,120 | $40,620 | 36.6% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 38 | 5,262 | $115,666 | $32,443 | 28.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 322 | $75,879 | $29,295 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 84 | 168 | $60,108 | $22,310 | 37.1% |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 2023 | 11 | 880 | $125,320 | $19,631 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 224 | 292 | $52,680 | $17,479 | 33.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 21 | 20,250 | $60,750 | $17,143 | 28.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 114 | $124,215 | $15,328 | 12.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 124 | 232 | $31,390 | $10,803 | 34.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 103 | 448 | $25,316 | $9,493 | 37.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 57 | $15,110 | $5,890 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 41 | $14,533 | $5,629 | 38.7% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 47 | 112 | $14,102 | $5,423 | 38.5% |
| J9395 | Injection, fulvestrant, 25 mg | Office | 2023 | 13 | 620 | $107,120 | $4,294 | 4.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 72 | $11,376 | $4,187 | 36.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 20 | 75 | $10,631 | $4,015 | 37.8% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 14 | 30 | $9,510 | $3,903 | 41.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 142 | 362 | $15,204 | $3,840 | 25.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 62 | 146 | $8,081 | $3,105 | 38.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 88 | 275 | $9,904 | $3,089 | 31.2% |
About Dr. James Neel, MD
Dr. James Neel, MD is a Hematology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447232772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Neel, MD has received a total of $860.50 in payments from pharmaceutical and medical device companies, with $99.00 received in 2023. These payments were reported across 48 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($699.63).
As a Medicare-enrolled provider, Neel has provided services to 11,918 Medicare beneficiaries, totaling 457,984 services with total Medicare billing of $6.9M. Data is available for 4 years (2020–2023), covering 216 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Melbourne, FL
- Active Since 11/14/2005
- Last Updated 05/17/2024
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1447232772
Products in Payments
- DARZALEX (Biological) $183.76
- ERLEADA (Drug) $116.69
- XTANDI (Drug) $68.90
- Avastin (Biological) $50.28
- Erivedge (Biological) $49.95
- ZYTIGA (Drug) $40.50
- Venclexta (Drug) $38.45
- TASIGNA (Drug) $37.32
- Blincyto (Biological) $27.69
- IMBRUVICA (Drug) $24.02
- IBRANCE (Drug) $23.89
- LUMAKRAS (Drug) $15.32
- SOLIRIS (Drug) $15.17
- BRAFTOVI (Drug) $15.10
- RYBREVANT (Drug) $15.00
- XPOVIO (Drug) $14.88
- Erleada (Drug) $13.85
- IMFINZI (Drug) $13.64
- MYLOTARG (Biological) $13.63
- Tavalisse (Drug) $13.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Melbourne
Dr. Ashish Dalal, Md, MD
Hematology — Payments: $10,660
Hematology $10,660
Dr. Amit Barochia, Md, MD
Hematology — Payments: $9,390
Hematology $9,390
Joseph Mcclure, Md, MD
Hematology — Payments: $6,188
Hematology $6,188
Dr. Germaine Blaine, Md, MD
Hematology — Payments: $1,452
Hematology $1,452
Dr. Mustafa Sahin, Md, MD
Hematology — Payments: $802.14
Hematology $802.14
Sean Kearin, Md, MD
Hematology — Payments: $404.03
Hematology $404.03